Evidence map›Paper›PMID 35599148›Full record

ArticleSemergen2022

[Adherence to influenza vaccination campaign 2020/21 in the pandemic SARS-CoV-2. Context analysis in management changes: A pilot study].

B Guerrero Cervera, M J Vindel Chaves, R J Roldán Quintanar, M Morales Suárez-Varela

Abstract readEnglish Abstract
In one paragraph

Article in Semergen, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

B Guerrero CerveraCentro de Atención Primaria Clot de Joan, Paterna, Valencia. Departamento de Salud, Hospital Arnau de Vilanova, Valencia, España; Área de Medicina Preventiva y Salud Pública, Departamento de Medicina Preventiva y Salud Pública, Ciencias de la Alimentación, Toxicología y Medicina Legal, Universitat de Valencia, Burjassot, Valencia, España.
M J Vindel ChavesCentro de Atención Primaria Clot de Joan, Paterna, Valencia. Departamento de Salud, Hospital Arnau de Vilanova, Valencia, España.
R J Roldán QuintanarCentro de Atención Primaria Clot de Joan, Paterna, Valencia. Departamento de Salud, Hospital Arnau de Vilanova, Valencia, España.
M Morales Suárez-VarelaÁrea de Medicina Preventiva y Salud Pública, Departamento de Medicina Preventiva y Salud Pública, Ciencias de la Alimentación, Toxicología y Medicina Legal, Universitat de Valencia, Burjassot, Valencia, España; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, España. Electronic address: maria.m.morales@uv.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVaccination campaigns against influenza virus achieve coverages under recommended and desired values. In current context of SARS-CoV-2 pandemic it becomes more relevant. Our objective is to evaluate the impact on vaccination coverage of a set of implementation strategies carried out. MATERIAL AND

methodsVaccine implementation strategies were introduced in our basic health zone as active caption of patients and schedule extension. Then the vaccination coverage achieved in the current campaign was evaluated and compared with previous in the 8th week and at the end of the campaign. Besides, a transversal study through a survey was carried out to measure the impact of the applied strategies.

resultsIn the 8th week of the campaign significant differences were detected in the increase of vaccination coverage compared with previous years. These results were confirmed at the end of the campaign, getting a significant difference (<.05) of vaccination coverage in all the studied centers, these data support the effectivity of the applied strategies.

conclusionsThe vaccine implementation strategies applied have shown effectivity, achieving an increase of until 74% in the total administered doses compared to previous campaigns and even a 15% of vaccination coverage increased in the group of patients older than 64 years; even in a pandemic context and the increasing of anti-vaccine movements.

Indexed as

COVID-19Influenza, HumanInfluenza VaccinesHumansImmunization ProgramsPandemicsPilot ProjectsSARS-CoV-2Influenza VaccinesAnti-vaccineAntivacunasCampaña de vacunaciónCobertura vacunalEstrategias de implementación vacunalGripeInfluenzaSARS-CoV-2Vaccination campaignVaccination coverageVaccine implementation strategies

Identifiers

PMID35599148
PMCPMC9068794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.